Cataract

Dexamethasone intraocular suspension shows strong anti-inflammatory effects

Real-world data on dexamethasone intraocular suspension 9% (DEXYCU, EyePoint Pharmaceuticals) show strong anti-inflammatory efficacy with and without additional topical anti-inflammatory treatment. The researchers examined the effect of adjunctive topical anti-inflammatory medications on clinical outcomes with sustained-release dexamethasone intraocular suspension 9%. Data were collected from records of patients who received dexamethasone...